Contribution of and Smoking Trends to US Incidence of Intestinal-Type Noncardia Gastric Adenocarcinoma: A Microsimulation Model

English version České info

Background:
Although gastric cancer has declined dramatically in the US, the disease remains the second leading cause of cancer mortality worldwide. A better understanding of reasons for the decline can provide important insights into effective preventive strategies. We sought to estimate the contribution of risk factor trends on past and future intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence.

Methods and Findings:
We developed a population-based microsimulation model of intestinal-type NCGA and calibrated it to US epidemiologic data on precancerous lesions and cancer. The model explicitly incorporated the impact of Helicobacter pylori and smoking on disease natural history, for which birth cohort-specific trends were derived from the National Health and Nutrition Examination Survey (NHANES) and National Health Interview Survey (NHIS). Between 1978 and 2008, the model estimated that intestinal-type NCGA incidence declined 60% from 11.0 to 4.4 per 100,000 men, <3% discrepancy from national statistics. H. pylori and smoking trends combined accounted for 47% (range = 30%–58%) of the observed decline. With no tobacco control, incidence would have declined only 56%, suggesting that lower smoking initiation and higher cessation rates observed after the 1960s accelerated the relative decline in cancer incidence by 7% (range = 0%–21%). With continued risk factor trends, incidence is projected to decline an additional 47% between 2008 and 2040, the majority of which will be attributable to H. pylori and smoking (81%; range = 61%–100%). Limitations include assuming all other risk factors influenced gastric carcinogenesis as one factor and restricting the analysis to men.

Conclusions:
Trends in modifiable risk factors explain a significant proportion of the decline of intestinal-type NCGA incidence in the US, and are projected to continue. Although past tobacco control efforts have hastened the decline, full benefits will take decades to be realized, and further discouragement of smoking and reduction of H. pylori should be priorities for gastric cancer control efforts.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Contribution of and Smoking Trends to US Incidence of Intestinal-Type Noncardia Gastric Adenocarcinoma: A Microsimulation Model. PLoS Med 10(5): e32767. doi:10.1371/journal.pmed.1001451
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001451

Souhrn

Zdroje

1. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002. cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon: IARCPress.

2. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, et al. (2012) SEER cancer statistics review, 1975–2009 (vintage 2009 populations). Bethesda (Maryland): National Cancer Institute. Available: http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.

3. HowsonCP, HiyamaT, WynderEL (1986) The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 8: 1–27.

4. IARC (1994) Schisotomes, liver flukes and helicobacter pylori. Monographs on the EVALuation of carcinogenic risks to humans number 61. Lyon: IARC Scientific Publishers.

5. BlotWJ, DevesaSS, KnellerRW, FraumeniJFJr (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287–1289.

6. CamargoMC, AndersonWF, KingJB, CorreaP, ThomasCC, et al. (2011) Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 60: 1644–1649.

7. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence - SEER 9 regs research data, Nov 2010 Sub (1973–2008) <Katrina/Rita Population Adjustment> - linked to county attributes - total U.S., 1969–2009 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. Available: www.seer.cancer.gov.

8. CorreaP (1992) Human gastric carcinogenesis: a multistep and multifactorial process–first American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735–6740.

9. KuipersEJ, UyterlindeAM, PenaAS, RoosendaalR, PalsG, et al. (1995) Long-term sequelae of Helicobacter pylori gastritis. Lancet 345: 1525–1528.

10. Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49: 347–353.

11. KatoI, VivasJ, PlummerM, LopezG, PerazaS, et al. (2004) Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 13: 468–476.

12. RussoA, MaconiG, SpinelliP, FeliceGD, EboliM, et al. (2001) Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. Am J Gastroenterol 96: 1402–1408.

13. KnellerRW, YouWC, ChangYS, LiuWD, ZhangL, et al. (1992) Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst 84: 1261–1266.

14. YouWC, ZhangL, GailMH, ChangYS, LiuWD, et al. (2000) Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 92: 1607–1612.

15. ChaoA, ThunMJ, HenleySJ, JacobsEJ, McCulloughML, et al. (2002) Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The Cancer Prevention Study II. Int J Cancer 101: 380–389.

16. Kruszon-MoranD, McQuillanGM (2005) Seroprevalence of six infectious diseases among adults in the United States by race/ethnicity: data from the third national health and nutrition examination survey, 1988–94. Adv Data 1–9.

17. McGinnisJM, ShoplandD, BrownC (1987) Tobacco and health: trends in smoking and smokeless tobacco consumption in the United States. Annu Rev Public Health 8: 441–467.

18. SchoenbornCA, AdamsPE (2010) Health behaviors of adults: United States, 2005–2007. Vital Health Stat 10: 1–132.

19. Surgeon General's Advisory Committee on Smoking and Health (1964) Smoking and health – report. Washington: U.S. Department of Health, Education and Welfare, Public Health Service, Center for Disease Control. PHS publication number 1103

20. LaurenPA (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Path Microbiol Scand 64: 31.

21. HensonDE, DittusC, YounesM, NguyenH, Albores-SaavedraJ (2004) Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med 128: 765–770.

22. WuH, RusieckiJA, ZhuK, PotterJ, DevesaSS (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 18: 1945–1952.

23. YehJM, KuntzKM, EzzatiM, HurC, KongCY, et al. (2008) Development of an empirically calibrated model of gastric cancer in two high-risk countries. Cancer Epidemiol Biomarkers Prev 17: 1179–1187.

24. XiaHH, TalleyNJ (1997) Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol 92: 1780–1787.

25. GisbertJP (2005) The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol 100: 2083–2099.

26. AndersonC, BurnsD, DoddK, FeuerE (2012) Chapter 2: birth-cohort-specific estimates of smoking behaviors for the U.S. population. Risk Analysis 32: S14–S24.

27. RosenbergM, FeuerE, YuB, SunJ, HenleyS, et al. (2012) Chapter 3: cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Analysis 32: S25–S38.

28. MoolgavkarSH, HolfordTR, LevyDT, KongCY, FoyM, et al. (2012) Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975–2000. J Natl Cancer Inst 104: 541–548.

29. DayNE, BrownCC (1980) Multistage models and primary prevention of cancer. J Natl Cancer Inst 64: 977–989.

30. Bell FC, Miller ML (2005) Life tables for the United States Social Security area 1900–2100. Baltimore (Maryland): Social Security Administration, Office of the Chief Actuary.

31. Thun MJ, Myers DG, Day-Lally C, Namboodiri MM, Calle EE, et al.. (1997) Chapter 5: age and the exposure-response relationships between cigarette smoking and premature death in cancer prevention study II. Burns DM, Garfinkel L, Samet JM, editors. Smoking and tobacco control monograph number 8 Changes in cigarette-related disease risks and their implications for prevention and control. NIH publication – number 97-4213. Bethesda (Maryland): National Institutes of Health, National Cancer Institute.

32. Day J (1996) Population projections of the United States by age, sex, race, and hispanic origin: 1995 to 2050. Washington (D.C.): U.S. Government Printing Office.

33. U.S. Census Bureau, Population Division (2011) Population estimates. Washington (D.C.): U.S. Census Bureau.

34. FennertyMB, EmersonJC, SamplinerRE, McGeeDL, HixsonLJ, et al. (1992) Gastric intestinal metaplasia in ethnic groups in the southwestern United States. Cancer Epidemiol Biomarkers Prev 1: 293–296.

35. FeuerEJ, LevyDT, McCarthyWJ (2012) Chapter 1: the impact of the reduction in tobacco smoking on U.S. Lung cancer mortality, 1975–2000: an introduction to the problem. Risk Anal 32 Suppl 1: S6–S13.

36. de MartelC, FerlayJ, FranceschiS, VignatJ, BrayF, et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13: 607–615.

37. HirayamaT (1984) Epidemiology of stomach cancer in Japan. With special reference to the strategy for the primary prevention. Jpn J Clin Oncol 14: 159–168.

38. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington (D.C.): American Institute for Cancer Research.

39. TsuganeS (2005) Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 96: 1–6.

40. ShikataK, KiyoharaY, KuboM, YonemotoK, NinomiyaT, et al. (2006) A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 119: 196–201.

41. WroblewskiLE, PeekRMJr, WilsonKT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23: 713–739.

42. TuomilehtoJ, GeboersJ, JoossensJV, SalonenJT, TanskanenA (1984) Trends in stomach cancer and stroke in Finland. Comparison to northwest Europe and USA. Stroke 15: 823–828.

43. PeleteiroB, La VecchiaC, LunetN (2011) The role of Helicobacter pylori infection in the web of gastric cancer causation. Eur J Cancer Prev 21: 118–125.

44. SheenE, TriadafilopoulosG (2011) Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci 56: 931–950.

45. AndersonWF, CamargoMC, FraumeniJFJr, CorreaP, RosenbergPS, et al. (2010) Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303: 1723–1728.

46. SchlanskyB, SonnenbergA (2011) Epidemiology of noncardia gastric adenocarcinoma in the United States. Am J Gastroenterol 106: 1978–1985.

47. LauM, LeA, El-SeragHB (2006) Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol 101: 2485–2492.

48. EdwardsBK, WardE, KohlerBA, EhemanC, ZauberAG, et al. (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116: 544–573.

49. BerryDA, InoueL, ShenY, VenierJ, CohenD, et al. (2006) Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr 30–36.

50. AhmadA, GovilY, FrankBB (2003) Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 98: 975–986.

51. Burns DM, Lee LL, Gilpin B, Tolley HD, Vaughn J, et al.. (1997) Chapter 2: Cigarette smoking behavior in the United States. Burns DM, Garfinkel L, Samet JM, editors. Smoking and tobacco control monograph number 8. Changes in cigarette-related disease risks and their implications for prevention and control NIH publication – number 97-4213. Bethesda (Maryland): National Institutes of Health, National Cancer Institute.

52. LopezA, CollishawNE, PihaT (1994) A descriptive model of the cigarette epidemic in developed countries. Tob Control 3: 242–247.

53. GradYH, LipsitchM, AielloAE (2012) Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol 175: 54–59.

54. MendezD, WarnerKE (2004) Adult cigarette smoking prevalence: declining as expected (not as desired). Am J Public Health 94: 251–252.

55. Smoking cessation during previous year among adults–United States, 1990 and 1991. MMWR Morb Mortal Wkly Rep 42: 504–507.